Partner Content Partner Content 1 week to SMi’s Superbugs & Superdrugs - REMOTE ACCESS ONLY 1 week to Superbugs & Superdrugs - REMOTE ACCESS ONLY
Partner Content Partner Content Interview with Martin Everett speaker at SMi’s Superbugs & S... Interview with Martin Everett speaker at Superbugs
Partner Content Partner Content Exclusive Interview with Martin Everett, CSO, Antabio, speak... Exclusive Interview with Martin Everett
Partner Content Partner Content Combioxin Speaking at SMi's 22nd Annual Superbugs & Superdru... Combioxin Speaking at SMi's 22nd Annual Superbugs
Partner Content Partner Content SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – S... SMi’s 22nd Annual Superbugs & Superdrugs Conference
Partner Content Partner Content Genentech develop Antibiotic with potential to lead to new c... Superbugs & Superdrugs 2019
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
